The roles of protein ubiquitination in tumorigenesis and targeted drug discovery in lung cancer
Z Ye, J Yang, H Jiang, X Zhan - Frontiers in Endocrinology, 2023 - frontiersin.org
The malignant lung cancer has a high morbidity rate and very poor 5-year survival rate.
About 80%-90% of protein degradation in human cells is occurred through the ubiquitination …
About 80%-90% of protein degradation in human cells is occurred through the ubiquitination …
A head-to-head comparison of [68Ga] Ga-DOTA-FGFR1 and [18F] FDG PET/CT in the diagnosis of lung cancer
H Yuan, X Chen, X Zhao, M Dai, Y Liu, J Han… - European Journal of …, 2025 - Springer
Purpose This study aimed to compare the diagnostic value of [68 Ga] Ga-DOTA-FGFR1 and
[18 F] FDG PET/CT in the evaluation of lung cancer patients. Methods A prospective study …
[18 F] FDG PET/CT in the evaluation of lung cancer patients. Methods A prospective study …
[HTML][HTML] Longitudinal circulating tumour DNA dynamics predict failure patterns and efficacy of consolidation immunotherapy after chemoradiotherapy in locally …
Y Wang, T Zhang, Y Yang, J Wang, C Li… - Clinical and …, 2024 - ncbi.nlm.nih.gov
Dear Editor, Responses to consolidation immune checkpoint inhibitor (ICI) in locally
advanced non-small-cell lung cancer (LANSCLC) are heterogeneous, and current decision …
advanced non-small-cell lung cancer (LANSCLC) are heterogeneous, and current decision …
The Incidence and Effect of Different Organ Metastasis on the Prognosis of NSCLC
S Wei, W Wei, B Wu, J Tian, P Hu… - The Thoracic and …, 2024 - thieme-connect.com
Objective The aim of this study was to explore the effect of different organ metastasis on the
prognosis of non-small cell lung cancer (NSCLC). Methods Patients with distant metastatic …
prognosis of non-small cell lung cancer (NSCLC). Methods Patients with distant metastatic …